Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
accredited, Adelaide, advocacy, aggressive, Altimmune, appetite, arbitrage, Australia, Australian, autotemcel, Axcella, bar, benchmark, biometric, blinded, Blvd, Boston, bribed, Bribery, bribing, Bristol, Carmot, ChemomAb, clesacostat, climate, CohBar, complicate, Corcept, Corrupt, corruption, currency, delivered, denominated, depth, dissemination, drought, EEA, efruxifermin, elivaldogene, ervogastat, ESG, EU, explored, FCPA, gastrointestinal, GDPR, GIP, great, improperly, insulin, insulinotropic, intercompany, job, lagging, landlord, laundering, lift, lodge, notification, outage, Pacific, pegozafermin, peptide, pharmacodynamic, Pharmatech, Pluristem, polypeptide, pressure, problem, prolonged, PTY, pursuit, remeasured, safeguarding, SD, sensitive, sensitivity, seventeen, sibling, subcutaneously, subsidiary, supervisory, tenant, threat, timeline, translated, translation, Truist, turnover, unsatisfactory, virtually, vital, Wainwright, weather, whichever
Filing tables
Filing exhibits
Related press release
Associated VKTX transcripts
VKTX similar filings
Filing view
External links
Exhibit 21.1
Subsidiaries of Viking Therapeutics, Inc.
Viking Therapeutics, PTY LTD (Australia)
LEGAL_US_W # 111055664.1